“…Limited tissue selectivity and the lack of targeting of anticancer therapeutics during systemic administration can result in deleterious side effects of anticancer chemotherapy [ 1 , 2 , 3 , 4 ]. To improve the efficacy of anticancer drugs, polymer-drug delivery carriers, including polymer conjugates, nanoparticles, and micelles, have been used to shield the therapeutics and prevent their premature release in healthy tissues [ 2 , 3 , 4 , 5 , 6 , 7 ]. Among those, polymer vesicles assembled from block copolymers, i.e., polymersomes, have been recognized as effective nanocarriers because of their cell-mimetic membranes, improved colloidal and mechanical stability, and increased efficiency in drug entrapment, unlike liposomes [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 ].…”